Your browser doesn't support javascript.
loading
Increased Foxp3+Helios+ Regulatory T Cells and Decreased Acute Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation in Patients Receiving Sirolimus and RGI-2001, an Activator of Invariant Natural Killer T Cells.
Chen, Yi-Bin; Efebera, Yvonne A; Johnston, Laura; Ball, Edward D; Avigan, David; Lekakis, Lazaros J; Bachier, Carlos R; Martin, Paul; Duramad, Omar; Ishii, Yasuyuki; Han, Semi; Jung, Yu-Jin; Lee, Dana; Kunkel, Lori; Negrin, Robert S; Bui, Jack D.
Afiliación
  • Chen YB; Bone Marrow Transplant Program, Massachusetts General Hospital Cancer Center, Boston, Massachusetts. Electronic address: ychen6@partners.org.
  • Efebera YA; Division of Hematology, The Ohio State University James Cancer Hospital, Columbus, Ohio.
  • Johnston L; Division of Blood and Marrow Transplantation, Stanford University, Stanford, California.
  • Ball ED; Division of Bone Marrow Transplantation, University of California San Diego, Moores UCSD Cancer Center, La Jolla, California.
  • Avigan D; Hematology-Oncology, Beth Israel Deacons Medical Center, Boston, Massachusetts.
  • Lekakis LJ; Division of Hematology/Oncology, University of Miami Hospital and Clinics, Sylvester Comprehensive Cancer Center, Miami, Florida.
  • Bachier CR; Sarah Cannon Center for Blood Cancer, Nashville, Tennessee.
  • Martin P; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Duramad O; REGiMMUNE Corporation, Tokyo, Japan.
  • Ishii Y; REGiMMUNE Corporation, Tokyo, Japan.
  • Han S; Department of Pathology, University of California San Diego, La Jolla, California.
  • Jung YJ; Department of Pathology, University of California San Diego, La Jolla, California.
  • Lee D; Medical Affairs 360, LLC, San Diego, California.
  • Kunkel L; D2D, LLC, San Francisco, California.
  • Negrin RS; Division of Blood and Marrow Transplantation, Stanford University, Stanford, California.
  • Bui JD; Department of Pathology, University of California San Diego, La Jolla, California. Electronic address: jbui@ucsd.edu.
Biol Blood Marrow Transplant ; 23(4): 625-634, 2017 Apr.
Article en En | MEDLINE | ID: mdl-28104514
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Médula Ósea / Linfocitos T Reguladores / Sirolimus / Galactosilceramidas / Enfermedad Injerto contra Huésped Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Humans / Middle aged Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2017 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Médula Ósea / Linfocitos T Reguladores / Sirolimus / Galactosilceramidas / Enfermedad Injerto contra Huésped Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Humans / Middle aged Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2017 Tipo del documento: Article